Omega-3 Fatty Acid Adjunctive to Open-Label Aripiprazole for the Treatment of Bipolar Disorder in Children and Adolescents
Clinical trial NCT00592683 · TERMINATED
Trial details
- NCT number
- NCT00592683
- Sponsor
- Massachusetts General Hospital
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2010-04-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.